SNC
BIIB icon

Stifel Nicolaus & Co’s Biogen BIIB Stock Holding History

Stifel Nicolaus & Co’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$4.08M Buy
16,927
+529
+3% +$118K 0.07% 283
2013
Q2 		$3.53M Buy
+16,398
New +$3.5M 0.06% 285

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Stifel Nicolaus & Co's BIIB Position: Q3 2013 in Review

Stifel Nicolaus & Co increased its Biogen (BIIB) stake by 3.2% in Q3 2013, buying an estimated $118K and bringing the position to 16,927 shares worth $4.08M. The position accounts for 0.07% of the portfolio, ranked #283.

Stifel Nicolaus & Co first reported a position in BIIB in Q2 2013 and has held it in 2 quarters since. 656 funds tracked by Wall St. Rank hold BIIB as of Q3 2013.

  • Stifel Nicolaus & Co held 16,927 shares of Biogen worth $4.08M as of Q3 2013.
  • Stifel Nicolaus & Co bought 529 Biogen shares in Q3 2013, an estimated $118K.
  • Biogen made up 0.07% of Stifel Nicolaus & Co's portfolio in Q3 2013, its #283 holding.
  • Stifel Nicolaus & Co first reported a position in Biogen in Q2 2013 and has held it in 2 quarters since.
  • 656 funds tracked by Wall St. Rank held Biogen as of Q3 2013.

Based on Stifel Nicolaus & Co's 13F filing for Q3 2013, filed 13 Nov 2013.